Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$6.01+0.63 (+11.81%)
Close on Nov 17, 2026Market cap $112.45MP/E –Yield –
Trinity Biotech cash
Cash and short-term investments held at the end of each period.
Trinity Biotech's cash was $5.14M at Dec 31, 2025. For fiscal 2025 it was $5.14M, down 0.6% from the year before. Over ten years it grew -25.8% a year on average. The highest annual figure on record is $101.95M in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.14M | -0.6% |
| FY2024 | Dec 31, 2024 | $5.17M | +40.0% |
| FY2023 | Dec 31, 2023 | $3.69M | -43.9% |
| FY2022 | Dec 31, 2022 | $6.58M | -74.6% |
| FY2021 | Dec 31, 2021 | $25.91M | -5.2% |
| FY2020 | Dec 31, 2020 | $27.33M | +79.4% |
| FY2019 | Dec 31, 2019 | $15.23M | -49.7% |
| FY2018 | Dec 31, 2018 | $30.28M | -47.4% |
| FY2017 | Dec 31, 2017 | $57.61M | -25.3% |
| FY2016 | Dec 31, 2016 | $77.11M | -24.4% |
| FY2015 | Dec 31, 2015 | $101.95M | +1020.1% |
| FY2014 | Dec 31, 2014 | $9.10M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $5.14M | +39.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.55M | -76.5% |
| Q4 FY2024 | Dec 31, 2024 | $5.17M | -50.6% |
| Q2 FY2024 | Jun 30, 2024 | $5.32M | -79.5% |
| Q4 FY2023 | Dec 31, 2023 | $3.69M | -86.5% |
| Q4 FY2022 | Dec 31, 2022 | $6.58M | -56.8% |
| Q2 FY2022 | Jun 30, 2022 | $10.45M | -65.5% |
| Q4 FY2021 | Dec 31, 2021 | $25.91M | -47.6% |
| Q4 FY2020 | Dec 31, 2020 | $27.33M | -49.3% |
| Q4 FY2019 | Dec 31, 2019 | $15.23M | -73.6% |
| Q4 FY2018 | Dec 31, 2018 | $30.28M | -52.7% |
| Q2 FY2018 | Jun 30, 2018 | $49.43M | -29.2% |
| Q1 FY2018 | Mar 31, 2018 | $53.90M | -30.1% |
| Q4 FY2017 | Dec 31, 2017 | $57.61M | -43.5% |
| Q2 FY2017 | Jun 30, 2017 | $63.98M | +602.9% |
| Q1 FY2017 | Mar 31, 2017 | $69.85M | – |
| Q4 FY2016 | Dec 31, 2016 | $77.11M | – |
| Q4 FY2015 | Dec 31, 2015 | $101.95M | – |
| Q4 FY2014 | Dec 31, 2014 | $9.10M | – |
See a number that looks wrong?